KALU vs NGVT
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
KALU presents a dichotomy between strong growth and deteriorating fundamental health, evidenced by a weak Piotroski F-Score of 3/9. While the stock has seen a massive 195.9% 1-year price surge and maintains a high growth-based intrinsic value of $199.42, it trades at a significant premium to its Graham Number of $88.45. The combination of bearish insider selling, a very weak technical trend (10/100), and high debt-to-equity relative to sector peers suggests the current valuation may be overextended despite strong top-line growth.
NGVT exhibits severe fundamental distress, highlighted by a weak Piotroski F-Score of 2/9 and an alarming Debt/Equity ratio of 41.84. Despite a 131% increase in share price over the last year, the company's core financials are deteriorating with negative ROE (-133.66%) and shrinking revenue (-14.60%). There is a massive divergence between the bullish price action and the catastrophic balance sheet, suggesting the current valuation is speculative rather than data-driven.
Compare Another Pair
Related Comparisons
KALU vs NGVT: Head-to-Head Comparison
This page compares Kaiser Aluminum Corporation (KALU) and Ingevity Corporation (NGVT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.